AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32382556 — intervention group
Group type: COMPARATOR
Intervention: Oral midazolam (MID)
Number of subjects: 60
Study 36631889 — intervention group
Group type: EXPERIMENTAL
Intervention: NICC (Novel Integrated Care Concept)
Number of subjects: 960
Study 36631889 — intervention group
Group type: COMPARATOR
Intervention: SoC (Standard of Care)
Number of subjects: 960
Study 33486150 — intervention group
Group type: EXPERIMENTAL
Intervention: CT/US
Number of subjects: 600
Study 33486150 — intervention group
Group type: COMPARATOR
Intervention: US
Number of subjects: 600
Study 33486150 — intervention group
Group type: COMPARATOR
Intervention: CT
Number of subjects: 600
Study 33486150 — intervention group
Group type: COMPARATOR
Intervention: CT, US, CT/US
Number of subjects: 600
Study 32389012 — intervention group
Group type: EXPERIMENTAL
Intervention: Qinzhuliangxue decoction (QZLXD)
Number of subjects: 176
Study 32389012 — intervention group
Group type: COMPARATOR
Intervention: Runzaozhiyang capsules (RZZYC)
Number of subjects: 176
Study 35421954 — intervention group
Group type: EXPERIMENTAL
Intervention: PTEBL teaching method combined with Caesar (trauma patient simulator)
Number of subjects: 78
Study 34795312 — intervention group
Group type: EXPERIMENTAL
Intervention: Precautionary behaviours
Number of subjects: 0
Study 34795312 — intervention group
Group type: EXPERIMENTAL
Intervention: Public confidence in government
Number of subjects: 0
Study 34795312 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological fatigue
Number of subjects: 0
Study 34795312 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological distress
Number of subjects: 0
Study 32830802 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious game for Symptom Self‐Management Training for Chemotherapy-Induced Nausea and Vomiting (CINV)
Number of subjects: 80
Study 32830802 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 80
Study 32830802 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 80
Study 32830802 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious game
Number of subjects: 80
Study 35816716 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BRJ): 140 mL; ∼8 mmol nitrate
Number of subjects: 20
Study 35816716 — intervention group
Group type: COMPARATOR
Intervention: Prune juice (CON): 166 mL; < 0.01 mmol nitrate
Number of subjects: 20
Study 35816716 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (BRJ)
Number of subjects: 20
Study 35816716 — intervention group
Group type: COMPARATOR
Intervention: Prune juice (CON)
Number of subjects: 20
Study 32826167 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic adipose-derived mesenchymal stem cells injection with standard diabetic wound care
Number of subjects: 20
Study 32826167 — intervention group
Group type: COMPARATOR
Intervention: Standard diabetic wound care
Number of subjects: 20
Study 35211042 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumetanide (max 1 mg twice daily)
Number of subjects: 38
Study 35211042 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 35211042 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumetanide
Number of subjects: 38
Study 33153062 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity Internet-Based Intervention focused on promoting Positive Affect
Number of subjects: 56
Study 33153062 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 56
Study 35303094 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal HD tDCS targeting left DLPFC
Number of subjects: 67
Study 35303094 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal HD tDCS targeting left IFG
Number of subjects: 67
Study 35303094 — intervention group
Group type: COMPARATOR
Intervention: Sham cathodal HD tDCS
Number of subjects: 67
Study 32767565 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium curettes
Number of subjects: 44
Study 32767565 — intervention group
Group type: COMPARATOR
Intervention: Chitosan brushes
Number of subjects: 44
Study 33034052 — intervention group
Group type: EXPERIMENTAL
Intervention: DDGP combined with RT
Number of subjects: 65
Study 33034052 — intervention group
Group type: COMPARATOR
Intervention: RT
Number of subjects: 65
Study 33007709 — intervention group
Group type: EXPERIMENTAL
Intervention: NiPPV (bilevel mode - Astral 150)
Number of subjects: 14
Study 33527182 — intervention group
Group type: EXPERIMENTAL
Intervention: 20G IAC
Number of subjects: 353
Study 33527182 — intervention group
Group type: EXPERIMENTAL
Intervention: 22G IAC
Number of subjects: 353
Study 33527182 — intervention group
Group type: EXPERIMENTAL
Intervention: 24G IAC
Number of subjects: 353
Study 33957299 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen supplementation (O2)
Number of subjects: 9
Study 33957299 — intervention group
Group type: COMPARATOR
Intervention: Medical air (Control)
Number of subjects: 9
Study 32747990 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronate
Number of subjects: 302
Study 34796595 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling
Number of subjects: 40
Study 34796595 — intervention group
Group type: COMPARATOR
Intervention: CO2 fractional laser
Number of subjects: 40
Study 32979383 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 98
Study 32979383 — intervention group
Group type: COMPARATOR
Intervention: No antibiotics
Number of subjects: 98
Study 33199437 — intervention group
Group type: EXPERIMENTAL
Intervention: Active NBM‐DBS
Number of subjects: 6
Study 33199437 — intervention group
Group type: COMPARATOR
Intervention: Sham NBM‐DBS
Number of subjects: 6
Study 36409489 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg/d)
Number of subjects: 251
Study 34446756 — intervention group
Group type: EXPERIMENTAL
Intervention: Total sleep time (TST)
Number of subjects: 164
Study 34446756 — intervention group
Group type: EXPERIMENTAL
Intervention: PSQI global score
Number of subjects: 164
Study 34608858 — intervention group
Group type: EXPERIMENTAL
Intervention: Newer nonwearable device (Beddit 3.5)
Number of subjects: 35
Study 34608858 — intervention group
Group type: EXPERIMENTAL
Intervention: Early version of the nonwearable device (Beddit 3.0)
Number of subjects: 35
Study 34608858 — intervention group
Group type: COMPARATOR
Intervention: Clinical-grade actigraphy
Number of subjects: 35
Study 34608858 — intervention group
Group type: COMPARATOR
Intervention: Self-reported sleep measures
Number of subjects: 35
Study 34289971 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antibiotics (used on ≥2 occasions)
Number of subjects: 5174
Study 34289971 — intervention group
Group type: COMPARATOR
Intervention: No use or a single report of oral antibiotics
Number of subjects: 5174
Study 34973967 — intervention group
Group type: EXPERIMENTAL
Intervention: Water Exchange (WE)
Number of subjects: 245
Study 34973967 — intervention group
Group type: COMPARATOR
Intervention: Air Insufflation (C)
Number of subjects: 245
Study 32030880 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling with tacrolimus
Number of subjects: 90
Study 32030880 — intervention group
Group type: COMPARATOR
Intervention: Microneedling only
Number of subjects: 90
Study 32030880 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus 0.1% ointment
Number of subjects: 90
Study 35443387 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril-valsartan (97mg-valsartan 103mg)
Number of subjects: 566
Study 35443387 — intervention group
Group type: COMPARATOR
Intervention: Ramipril (5mg twice daily)
Number of subjects: 566
Study 35443387 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril-valsartan
Number of subjects: 566
Study 35443387 — intervention group
Group type: COMPARATOR
Intervention: Ramipril
Number of subjects: 566
Study 33678596 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision Aid (DA)
Number of subjects: 33
Study 32946924 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacituzumab govitecan (SG; 10 mg/kg)
Number of subjects: 54
Study 36183733 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant (500 mg intramuscularly on day 1 of each 28‐day cycle and on day 15 of cycle 1) and palbociclib (125 mg orally once per day on days 1‐21 of a 28‐day cycle)
Number of subjects: 172
Study 36183733 — intervention group
Group type: COMPARATOR
Intervention: Aromatase inhibitor (2·5 mg letrozole, 1 mg anastrozole, or 25 mg exemestane, orally once per day, taken continuously) and palbociclib (125 mg orally once per day on days 1‐21 of a 28‐day cycle)
Number of subjects: 172
Study 36183733 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 172
Study 36183733 — intervention group
Group type: COMPARATOR
Intervention: Aromatase inhibitor and palbociclib group
Number of subjects: 172
Study 36183733 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant and palbociclib group
Number of subjects: 172
Study 33793753 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforced stapling
Number of subjects: 106
Study 33793753 — intervention group
Group type: COMPARATOR
Intervention: Standard stapling
Number of subjects: 106
Study 33129609 — intervention group
Group type: EXPERIMENTAL
Intervention: AV7909 (three doses at Days 1, 15, and 29)
Number of subjects: 305
Study 33129609 — intervention group
Group type: EXPERIMENTAL
Intervention: AV7909 (two doses at Days 1 and 29)
Number of subjects: 305
Study 33129609 — intervention group
Group type: COMPARATOR
Intervention: BioThrax
Number of subjects: 305
Study 34985171 — intervention group
Group type: COMPARATOR
Intervention: Brief Advice (BA)
Number of subjects: 903
Study 34985171 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate Reduction (RR)
Number of subjects: 903
Study 34985171 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 903
Study 34985171 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined MI and Rate Reduction (MI+RR)
Number of subjects: 903
Study 34304438 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1,500 mg/d)
Number of subjects: 200
Study 34304438 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (4 mg/d)
Number of subjects: 200
Study 32650518 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimebutine maleate (TM) 300 mg twice per day (BID) for 4 weeks
Number of subjects: 211
Study 32650518 — intervention group
Group type: COMPARATOR
Intervention: Placebo BID for 4 weeks
Number of subjects: 211
Study 32650518 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimebutine maleate (TM)
Number of subjects: 211
Study 32650518 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 211
Study 34857226 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFA (3680 mg/day)
Number of subjects: 16
Study 34857226 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 34857226 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFA
Number of subjects: 16
Study 34857226 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 16
Study 34672349 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous trabectedin (1.5 mg/m2 every 3 weeks)
Number of subjects: 90
Study 34672349 — intervention group
Group type: COMPARATOR
Intervention: Local standard of care (LOC)
Number of subjects: 90
Study 33080817 — intervention group
Group type: EXPERIMENTAL
Intervention: Velocity-monitored resistance training (RT) with a velocity loss of 20%, 2 sessions per week for 10 weeks
Number of subjects: 39
Study 33080817 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) maintaining daily routine
Number of subjects: 39
Study 33482048 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression Scale for Children
Number of subjects: 535
Study 33482048 — intervention group
Group type: EXPERIMENTAL
Intervention: UCLA Loneliness Scale
Number of subjects: 535
Study 33482048 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear regression analysis for depression and UCLA loneliness score
Number of subjects: 535
Study 33324478 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous Hematopoietic Stem Cell Transplantation (auto‐HSCT)
Number of subjects: 101
Study 33324478 — intervention group
Group type: COMPARATOR
Intervention: Intensive cytarabine‐based chemotherapy
Number of subjects: 101
Study 32743763 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary zinc intake
Number of subjects: 142
Study 35865342 — intervention group
Group type: EXPERIMENTAL
Intervention: Qinpi Tongfeng Formula (QPTFF)
Number of subjects: 114
Study 35865342 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac sodium sustained-release tablets
Number of subjects: 114
Study 32387499 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreaticobiliary (BP) master system for EUS training
Number of subjects: 0
Study 34935760 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial levels of cancer-related stress (T1)
Number of subjects: 120
Study 34935760 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial levels of IL-6 (T1)
Number of subjects: 120
Study 34935760 — intervention group
Group type: EXPERIMENTAL
Intervention: Dropping social roles over time (T1 to T3)
Number of subjects: 120
Study 32318722 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based monitoring
Number of subjects: 260
Study 32318722 — intervention group
Group type: COMPARATOR
Intervention: Hospital-based monitoring
Number of subjects: 260
Study 34487008 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilization Exercises (SE)
Number of subjects: 37
Study 34487008 — intervention group
Group type: COMPARATOR
Intervention: Conventional Exercises (CE)
Number of subjects: 37
Study 32317213 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led delirium prevention protocol
Number of subjects: 0
Study 36314861 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained physician group
Number of subjects: 283
Study 36314861 — intervention group
Group type: COMPARATOR
Intervention: Untrained physician group
Number of subjects: 283
Study 36314861 — intervention group
Group type: EXPERIMENTAL
Intervention: Both trained and untrained physician groups
Number of subjects: 283
Study 33734289 — intervention group
Group type: COMPARATOR
Intervention: 4 cycles of mitomycin/vindesine/cisplatin plus thoracic radiotherapy (TRT) of 60 Gy
Number of subjects: 440
Study 33734289 — intervention group
Group type: EXPERIMENTAL
Intervention: weekly irinotecan/carboplatin for 6 weeks plus TRT of 60 Gy followed by 2 courses of irinotecan/carboplatin consolidation
Number of subjects: 440
Study 33734289 — intervention group
Group type: EXPERIMENTAL
Intervention: weekly paclitaxel/carboplatin for 6 weeks plus TRT of 60 Gy followed by 2 courses of paclitaxel/carboplatin consolidation
Number of subjects: 440
Study 32776220 — intervention group
Group type: EXPERIMENTAL
Intervention: Three 10‐min bouts of exercise (ACC)
Number of subjects: 10
Study 32776220 — intervention group
Group type: COMPARATOR
Intervention: Single 30‐min bout of exercise (CONT)
Number of subjects: 10
Study 35667781 — intervention group
Group type: EXPERIMENTAL
Intervention: 99DOTS intervention
Number of subjects: 18
Study 33382137 — intervention group
Group type: EXPERIMENTAL
Intervention: One-step SEMS placement
Number of subjects: 90
Study 33382137 — intervention group
Group type: COMPARATOR
Intervention: Two-step SEMS placement
Number of subjects: 90
Study 35988255 — intervention group
Group type: EXPERIMENTAL
Intervention: Jacobson's relaxation technique along with Bhastrika Pranayama
Number of subjects: 30
Study 35988255 — intervention group
Group type: COMPARATOR
Intervention: Diaphragmatic breathing exercises and chest expansion exercises
Number of subjects: 30
Study 33563767 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral V3 block with ropivacaine 0.75% (block group, n=50)
Number of subjects: 107
Study 33563767 — intervention group
Group type: COMPARATOR
Intervention: Placebo (placebo group, n=57)
Number of subjects: 107
Study 36254912 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant erythropoietin (500 IU/kg) administered one to three days before surgery
Number of subjects: 66
Study 36254912 — intervention group
Group type: COMPARATOR
Intervention: Control group (no recombinant erythropoietin)
Number of subjects: 66
Study 32851532 — intervention group
Group type: EXPERIMENTAL
Intervention: Deproteinized bovine bone mineral (DBBM) covered by a synthetic polylactic membrane (test group)
Number of subjects: 8
Study 32851532 — intervention group
Group type: EXPERIMENTAL
Intervention: DBBM plus a porcine natural collagen membrane (positive control)
Number of subjects: 8
Study 32851532 — intervention group
Group type: COMPARATOR
Intervention: Defect only covered by the synthetic membrane (negative control group)
Number of subjects: 8
Study 32998759 — intervention group
Group type: EXPERIMENTAL
Intervention: SI-Bord screening instrument
Number of subjects: 342
Study 32998759 — intervention group
Group type: EXPERIMENTAL
Intervention: SI-Bord score
Number of subjects: 342
Study 32998759 — intervention group
Group type: EXPERIMENTAL
Intervention: Cut-off score > 9 for SI-Bord
Number of subjects: 342
Study 34376153 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose sodium thiopental (5 mg/kg)
Number of subjects: 80
Study 34376153 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose sodium thiopental (7 mg/kg)
Number of subjects: 80
Study 32316660 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat challenge
Number of subjects: 26
Study 32316660 — intervention group
Group type: COMPARATOR
Intervention: Rice challenge
Number of subjects: 26
Study 36152018 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral function intervention (EG) including oral exercise and preventive oral care, with a reminder phone call every 2 weeks
Number of subjects: 114
Study 36152018 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral function intervention (EG)
Number of subjects: 114
Study 35585836 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 32
Study 35585836 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 32
Study 34726788 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab and chemotherapy
Number of subjects: 0
Study 34726788 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropathic AEs trajectory
Number of subjects: 0
Study 34726788 — intervention group
Group type: EXPERIMENTAL
Intervention: High-grade AE trajectory
Number of subjects: 0
Study 35805687 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified osteotome sinus floor elevation (OSFE) technique
Number of subjects: 30
Study 34876195 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-thickness skin graft technique
Number of subjects: 0
Study 34876195 — intervention group
Group type: COMPARATOR
Intervention: Conventional synthetic composite mesh
Number of subjects: 0
Study 35821118 — intervention group
Group type: COMPARATOR
Intervention: Proximal femoral nail (PFN) alone
Number of subjects: 60
Study 35821118 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal femoral nail augmented with trochanteric buttress plate (PFN + TBP)
Number of subjects: 60
Study 34939897 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 3025
Study 34939897 — intervention group
Group type: EXPERIMENTAL
Intervention: Oncogenic HPV types
Number of subjects: 3025
Study 32905615 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole (MTZ) + Amoxicillin (AMX) + Scaling and Root Planing (SRP)
Number of subjects: 25
Study 32905615 — intervention group
Group type: COMPARATOR
Intervention: Scaling and Root Planing (SRP) only
Number of subjects: 25
Study 32049833 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-based rehabilitation
Number of subjects: 85
Study 32049833 — intervention group
Group type: COMPARATOR
Intervention: Traditional rehabilitation
Number of subjects: 85
Study 35442211 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Q-learning (DQL) treatment decisions
Number of subjects: 536
Study 32938866 — intervention group
Group type: EXPERIMENTAL
Intervention: TR‐RPDs
Number of subjects: 24
Study 32938866 — intervention group
Group type: COMPARATOR
Intervention: MC‐RPDs
Number of subjects: 24
Study 32331052 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariprazine 1.5-3 mg/d
Number of subjects: 1383
Study 32331052 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1383
Study 35690076 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week priming interval with homologous BNT162b2
Number of subjects: 730
Study 35690076 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week priming interval with homologous ChAdOx1 nCoV-19
Number of subjects: 730
Study 35690076 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week priming interval with heterologous BNT162b2-ChAdOx1 nCoV-19
Number of subjects: 730
Study 35690076 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week priming interval with heterologous ChAdOx1 nCoV-19-BNT162b2
Number of subjects: 730
Study 35690076 — intervention group
Group type: EXPERIMENTAL
Intervention: All 12-week interval groups
Number of subjects: 730
Study 35690076 — intervention group
Group type: EXPERIMENTAL
Intervention: Homologous BNT162b2
Number of subjects: 730
Study 35690076 — intervention group
Group type: EXPERIMENTAL
Intervention: All 12-week priming intervals
Number of subjects: 730
Study 35690076 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week schedules for homologous BNT162b2 and ChAdOx1 nCoV-19-BNT162b2
Number of subjects: 730
Study 33971289 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blocker use
Number of subjects: 14434
Study 33971289 — intervention group
Group type: COMPARATOR
Intervention: Nonuse of β-blockers (Control)
Number of subjects: 14434
Study 32522811 — intervention group
Group type: EXPERIMENTAL
Intervention: Full intervention (mail plus phone calls)
Number of subjects: 2632
Study 32522811 — intervention group
Group type: EXPERIMENTAL
Intervention: Mail only
Number of subjects: 2632
Study 32522811 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2632
Study 34648188 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdiagnostic web-based skills training program with telehealth-delivered coaching
Number of subjects: 32
Study 616636799 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted comments
Number of subjects: 289
Study 616636799 — intervention group
Group type: COMPARATOR
Intervention: Rubric delivery method (electronic or paper)
Number of subjects: 289
Study 616636799 — intervention group
Group type: EXPERIMENTAL
Intervention: Rubric viewing rates
Number of subjects: 289
Study 616636799 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall performance over time
Number of subjects: 289
Study 616636799 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference for rubric method
Number of subjects: 289